Carillon Tower Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$28M Sell
202,025
-17,220
-8% -$2.38M 0.17% 183
2020
Q3
$18M Buy
219,245
+17,220
+9% +$1.42M 0.24% 153
2020
Q2
$15.8M Buy
+202,025
New +$15.8M 0.12% 239